New York Urological Associates, PC

New York, New York 10022

0 studies enrolling now · 2 studies all time

What they study most

Hormone-Refractory Prostate Cancer, Overactive Bladder Syndrome (OABS)

Studies at this site

• SMP-986 Phase 2 Proof of Concept in Patients With Overactive Bladder Syndrome (OABS) — Completed
• Multi-Center Phase II Study to Compare MER-101 20mg Tablets to Intravenous Zometa 4mg in Male Bisphosphonate-Naive, Hormone Refractory Prostate Cancer Patients — Completed